1. Home
  2. GRFS vs MTN Comparison

GRFS vs MTN Comparison

Compare GRFS & MTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • MTN
  • Stock Information
  • Founded
  • GRFS 1940
  • MTN 1997
  • Country
  • GRFS Spain
  • MTN United States
  • Employees
  • GRFS N/A
  • MTN N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • MTN Services-Misc. Amusement & Recreation
  • Sector
  • GRFS Health Care
  • MTN Consumer Discretionary
  • Exchange
  • GRFS Nasdaq
  • MTN Nasdaq
  • Market Cap
  • GRFS 5.9B
  • MTN 5.1B
  • IPO Year
  • GRFS 2006
  • MTN 1997
  • Fundamental
  • Price
  • GRFS $8.39
  • MTN $136.05
  • Analyst Decision
  • GRFS Hold
  • MTN Buy
  • Analyst Count
  • GRFS 1
  • MTN 9
  • Target Price
  • GRFS $10.30
  • MTN $176.78
  • AVG Volume (30 Days)
  • GRFS 779.1K
  • MTN 707.2K
  • Earning Date
  • GRFS 01-01-0001
  • MTN 12-10-2025
  • Dividend Yield
  • GRFS 1.70%
  • MTN 6.58%
  • EPS Growth
  • GRFS N/A
  • MTN 23.64
  • EPS
  • GRFS 0.64
  • MTN 7.53
  • Revenue
  • GRFS $8,821,017,248.00
  • MTN $2,964,347,000.00
  • Revenue This Year
  • GRFS $5.31
  • MTN $2.72
  • Revenue Next Year
  • GRFS $6.02
  • MTN $3.48
  • P/E Ratio
  • GRFS $16.23
  • MTN $17.93
  • Revenue Growth
  • GRFS 7.31
  • MTN 2.74
  • 52 Week Low
  • GRFS $6.19
  • MTN $129.85
  • 52 Week High
  • GRFS $11.14
  • MTN $199.45
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 33.65
  • MTN 37.23
  • Support Level
  • GRFS $8.33
  • MTN $132.66
  • Resistance Level
  • GRFS $8.64
  • MTN $144.21
  • Average True Range (ATR)
  • GRFS 0.21
  • MTN 4.60
  • MACD
  • GRFS -0.00
  • MTN -1.05
  • Stochastic Oscillator
  • GRFS 26.21
  • MTN 19.48

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About MTN Vail Resorts Inc.

Vail Resorts Inc Bhd is a resorts and casinos company that operates mountain resorts and ski areas. The company has three business segments that include Mountain, Lodging, and Real Estate. The Mountain segment operates numerous ski resort properties that offer a variety of winter and summer activities, such as skiing, snowboarding, snowshoeing, hiking, and mountain biking. The Lodging segment owns and operates hotels and condominiums. The Real Estate segment owns, develops, and leases real estate, typically near its other properties. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: